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Exogenous oocyte secreted factors such as bone morphogenetic protein 15 (BMP15), together 53 
with hormones traditionally used during in vitro oocyte maturation, increase the developmental 54 
competence of cumulus oocyte complexes (COCs). Separately, FSH and BMP15 induce 55 
different metabolic profiles within COCs, namely FSH increases glycolysis while BMP15 56 
stimulates FAD and NAD(P)H auto-fluorescence within oocytes, without changing the REDOX 57 
ratio. Hence, the aim of this study was to investigate if BMP15-induced increased NAD(P)H 58 
was due to NADPH production. Cattle COCs were cultured with FSH and/or recombinant 59 
human BMP15 (BMP15). Following culture with BMP15, there was a significant decrease in 60 
glucose 6-phosphate dehydrogenase activity (P<0.05). Treatment with an inhibitor of isocitrate 61 
dehydrogenase (IDH) decreased NAD(P)H intensity 3-fold in BMP15 treated oocytes, 62 
suggesting BMP15 stimulates IDH and NADPH production via the TCA cycle.  As NADPH is a 63 
reducing agent, reduced glutathione (GSH), H2O2 and mitochondrial activity were measured. 64 
FSH alone decreased GSH levels within the oocyte, with the combination of BMP15 and FSH 65 
recovering levels. Expression of genes encoding glutathione-reducing enzymes were also 66 
lower in oocytes cultured in the presence of FSH.  However, BMP15 supplementation 67 
promoted mitochondrial localisation patterns consistent with enhanced developmental 68 
competence. Metabolomics revealed there was significant consumption of glutamine and 69 
production of alanine by COCs +FSH +BMP15 compared to the control (P<0.05). Hence, this 70 
study demonstrates that BMP15 supplementation differentially modulates reductive metabolism 71 
and mitochondrial localisation within the oocyte.  In comparison, FSH-stimulation alone 72 
decreases the oocyte’s ability to regulate cellular stress and therefore utilizes other 73 
mechanisms to improve developmental competence.74 
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INTRODUCTION 75 
During the final stages of oocyte development and immediately prior to ovulation, the oocyte 76 
and surrounding specialised somatic cells (cumulus cells) exhibit a symbiotic relationship 77 
(Albertini et al. 2001; Matzuk et al. 2002), and are referred to as the cumulus oocyte complex 78 
(COC). Bi-directional communication between the two cell populations is critical for oocyte 79 
developmental competence (the ability of the oocyte to undergo successful fertilisation and 80 
embryo development) and is facilitated by paracrine and gap junction communication (Larsen 81 
and Wert 1988; Buccione et al. 1990a; Albertini et al. 2001). Cumulus cells provide the oocyte 82 
with nutrients and factors essential for maturation (Sutton et al. 2003; Krisher 2013). In return, 83 
the oocyte secretes growth factors (oocyte secreted factors; OSF), that facilitates differentiation 84 
of cumulus cells from other ovarian cells (Li et al. 2000), mucification and proliferation 85 
(Buccione et al. 1990; Salustri et al. 1990a; Salustri et al. 1990b), increases steriodogenesis 86 
(Vanderhyden and Macdonald 1998) and prevents apoptosis (Hussein et al. 2005). Growth 87 
differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are members of 88 
the transforming growth factor beta superfamily and have been identified as key OSF (Su et al. 89 
2004). In particular, BMP15 is potent promoter of oocyte developmental competence in large, 90 
mono-ovular species such as cattle (Hussein et al. 2006; Crawford and McNatty 2012). 91 
 92 
We have previously reported that recombinant human BMP15 and follicle stimulating hormone 93 
(FSH; a potent stimulator of COC metabolism and a common media additive during IVM) 94 
supplementation significantly increases bovine oocyte developmental competence (as 95 
indicated by increased on-time blastocyst yield; –FSH –BMP15 = 28.4 ± 7.4% vs. +FSH 96 
+BMP15 = 51.5 ± 5.4% total blastocysts/cleaved; P < 0.05), yet when added individually, they 97 
stimulate different metabolic activities within COCs, despite similar blastocyst yields (+FSH = 98 
44.4 ± 3.9 vs. +BMP15 = 41 ± 2.9% total blastocysts/cleaved; P > 0.05) (Sutton-McDowall et 99 
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al. 2012). FSH-stimulates glucose metabolism via glycolysis and the hexosamine biosynthetic 100 
pathway in cumulus cells, indicated by increased lactate production and mucification leading to 101 
cumulus expansion; while BMP15 alone stimulates oxidative phosphorylation (as measured by 102 
FAD auto-fluorescence) and increased NAD(P)H levels within oocytes. Furthermore, the 103 
influence of FSH and BMP15 on oocyte metabolism was mediated via cumulus cells, as the 104 
oocyte itself exhibits low levels of glycolytic activity (Sutton-McDowall et al. 2012) and 105 
increases in intra-oocyte FAD and NAD(P)H levels were only detected in cumulus enclosed 106 
oocytes (Sutton-McDowall et al. 2012). 107 
 108 
While FAD is the oxidised co-factor of FADH2 within Complex II of the respiratory chain 109 
(mitochondria), NAD(P)H represents both NADH and NADPH (Mayevsky and Chance 1982; 110 
Skala and Ramanujam 2010), which are reducing agents and co-factors involved in numerous 111 
metabolic pathways. NADH is a co-factor for several metabolic enzymes, such as lactate 112 
dehydrogenase (cytoplasmic), and is a proton donor within Complex I of the respiratory chain 113 
within mitochondria, thus oxidised to NAD+. NADPH is a co-factor for several enzymes, 114 
including 6-phosphogluconate dehydrogenase during glucose metabolism through the pentose 115 
phosphate pathway (cytoplasmic), and isocitrate dehydrogenase (IDH; TCA cycle within the 116 
mitochondria). Although the auto-fluorescence technique utilised in our previous study was 117 
unable to distinguish between NADH and NADPH (Sutton-McDowall et al. 2012), in somatic 118 
cells the majority of NAD(P)H auto-fluorescence represents NADH (Chance et al. 1979). 119 
Because BMP15 stimulates COCs to increase oxidative phosphorylation over glycolysis, an 120 
increased REDOX ratio (FAD:NAD(P)H) was predicted.  However, this was not observed 121 
(Sutton-McDowall et al. 2012). Hence, BMP15 could also increase the yield of intra-oocyte 122 
NADPH.  123 
 124 
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While the oocyte itself has a low capacity for glucose uptake and metabolism (Sutton-McDowall 125 
et al. 2010), the pentose phosphate pathway is thought to be important for oocyte maturation 126 
by the provision of substrates for de novo nucleic acid synthesis and therefore is the primary 127 
source of oocyte NADPH (Downs et al. 1998). However, this has been challenged recently by 128 
the demonstration that IDH within the TCA cycle supplies the majority of NADPH within mouse 129 
oocytes (Dumollard et al. 2007b). Furthermore, only NADP-dependent IDH activity is detected 130 
in bovine cumulus cells and oocytes (Cetica et al. 2003). 131 
 132 
Regardless of the source, NADPH plays an important role in preventing overt levels of reactive 133 
oxygen species (ROS) within the oocyte. Thiol compounds such as glutathione are innate 134 
antioxidants, by donating hydrogens to convert hydrogen peroxide (H2O2) to water. Oxidised 135 
glutathione (GSSG) is reduced (GSH) by glutathione reductase (GSR) and glutathione S-136 
transferase (GSTA), which requires NADPH as a co-factor. GSH is important to cellular health 137 
and in regards to the oocyte, acquisition of higher levels of reduced glutathione during oocyte 138 
maturation is associated with improved developmental competence (Takahashi et al. 1993; de 139 
Matos et al. 1995; Sanchez et al. 2013). 140 
 141 
The aim of this study was to investigate the differential metabolic profiles of cattle COCs 142 
exposed to FSH and BMP15. In particular, we investigated the source of the increased 143 
NAD(P)H levels within the oocyte, following stimulation by BMP15 alone and the consequences 144 
of elevated NAD(P)H levels in respect to intra-oocyte levels of reduced glutathione, 145 
mitochondrial activity/localisation and ROS levels.  146 
 147 
RESULTS 148 
Experiment 1: Intra-oocyte glucose 6-phosphate dehydrogenase (G6PDH) activity  149 
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To determine if increased NAD(P)H auto-fluorescence within the oocyte, following exposure to 150 
BMP15, were due to increased G6PDH (pentose phosphate pathway), COCs were cultured in 151 
the presence of brilliant cresyl blue (BCB; metabolised by G6PDH), with BCB- oocytes 152 
indicating active enzymatic activity. The proportion of BCB- oocytes after 23 h of culture did not 153 
vary between the control, +FSH and +FSH +BMP15 treatments (Figure 1). However, there 154 
was a main effect of BMP15 supplementation, with the proportion of BCB- oocytes following 155 
culture in +BMP15 -FSH significantly lower than all the other groups (control = 90.8  3.4% vs. 156 
+BMP15 = 62.4 ± 5.7%; P < 0.05). As BMP15 treatment decreased G6PDH activity within the 157 
oocyte, these results suggest that the pentose phosphate pathway is not the primary source of 158 
NADPH following BMP15 stimulation.  159 
 160 
Experiment 2: Intra-oocyte isocitrate dehydrogenase (IDH) activity and NAD(P)H levels 161 
To determine if the increased NAD(P)H levels within the oocyte following culture in the 162 
presence of BMP15 alone was due to increased IDH activity (TCA cycle), COCs were cultured 163 
in the presence or absence of BMP15, followed by oxalomalate, an inhibitor of IDH. A dose of 1 164 
mM was used as the presence of 5 mM resulted in high levels of background fluorescence in 165 
the 405 nm excitation/420-520 nm emission spectrum (blue filter, Supplementary Figure S1). 166 
Autofluorescence (NAD(P)H and FAD) was then measured within the oocyte.  167 
 168 
In the absence of BMP15 (control), there were no significant differences in oocyte NAD(P)H 169 
auto-fluorescence intensity between 0 and 1 mM oxalomalate treatments (Figure 2A). COCs 170 
cultured in the presence of BMP15 had significantly higher intra-oocyte NAD(P)H intensity 171 
compared to the control groups. In contrast, intensity was significantly lower and at similar 172 
levels to the control groups in oocytes exposed to BMP15 and 1 mM oxalomalate (P < 0.05; 173 
Figure 2A).  174 
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 175 
A similar pattern of fluorescence intensity was seen for FAD, with the control groups having 176 
similar intensities regardless of oxalomalate treatment (Figure 2B). The significant increase in 177 
FAD intensity in the presence of BMP15 (P < 0.05) was reversed in the presence of 1 mM 178 
oxalomalate. Hence, oxalomalate treatment reduced the BMP15-mediated increases in 179 
NAD(P)H and FAD, most likely through reduced TCA cycle activity, suggesting the TCA cycle 180 
is a major source of NADPH within BMP15-treated oocytes. 181 
 182 
Experiment 3: Intra-oocyte reduced glutathione (GSH), mitochondrial activity and 183 
reactive oxygen species (ROS) levels 184 
Following 23 h cultures in the presence or absence of FSH and BMP15, COCs were labelled 185 
with monochlorobimane (MCB; for GSH determination), peroxyfluor 1 (PF1; for H2O2 186 
determination) and Mitotracker Red CMXROS (active mitochondria) to determine if the 187 
presence of FSH and BMP15 influenced mitochondrial activity and localisation, cellular stress 188 
in the form of ROS (H2O2) and endogenous anti-oxidation protection in the form of GSH. In 189 
COCs cultured in the presence of FSH alone, there was a significant decrease in the mean 190 
intensity of intra-oocyte MCB compared to all the other treatment groups (MCB reflecting GSH 191 
levels; Figure 3A&D, P < 0.001). In comparison, positive staining for active mitochondria was 192 
significantly higher within oocytes exposed to FSH during IVM, compared to the control group 193 
(Mitotracker Red as a measure for active mitochondria; Figure 3B&D, P < 0.05). Alone, 194 
BMP15 and FSH significantly increased PF1 levels, compare to the control but not the +FSH 195 
+BMP15 group (PF1 determines H2O2; Figure 3C&D).  196 
 197 
To resolve whether BMP15 and FSH supplementation during IVM influenced the localisation of 198 
GSH, H2O2 and active mitochondria within the oocyte, image texure analyses (with the help of 199 
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grey-level co-occurrence matrices, GLCM) were performed. Higher values of textural features 200 
indicate higher levels of roughness/unevenness and reduced uniformity of positive staining. As 201 
similar patterns of localisation were seen for the angular secondary moment (ASM, the texture 202 
of the whole oocyte), contrast (sub-cellular/organelle texture) and correlation (relationships 203 
between neighbouring pixels); the ASM data is presented in Figure 4, with the remaining 204 
texture data presented in Supplementary Figure S2  205 
 206 
There were no significant differences in the texture patterns of MCB positive staining 207 
(representing GSH) across treatments, with large variations in patterns seen within all groups 208 
(Figure 4A, P > 0.05). However, with both PF1 (representing H2O2) and Mitotracker Red 209 
localisation, BMP15 supplementation resulted in significantly lower texture values, hence 210 
smoother patterns of positive staining (main effect of BMP15; Mitotracker Red P = 0.005 and 211 
PF1; P = 0.003). Furthermore, BMP15 supplementation resulted in more consistent texture 212 
feature values within the Mitotracker Red and PF1 staining compared to the control group, 213 
which had large variations in texture values, as indicated by the SEM bars (Figures 4B&C).  214 
 215 
In summary, FSH-stimulation reduced levels of GSH-positive staining within oocytes and 216 
increased mitochondrial activity and production of ROS in the form of H2O2.  ROS-levels were 217 
also higher in BMP15-treated oocytes, regardless of the presence or absence of FSH. 218 
Furthermore, BMP15-treatment also promoted a more uniform localisation of mitochondrial 219 
localisation.  220 
 221 
Experiment 4: Gene expression within the oocyte and cumulus vestment 222 
The gene expression of key enzymes involved in glutathione synthesis and cycling, such as 223 
glutathione biosynthesis (GSS), reduction (GSR, GSTA1) and oxidation (GPX1, GPX4) were 224 
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measured in cumulus cells (CC) and COC-derived denuded oocytes (CDO) following 23 h IVM 225 
in the presence or absence of BMP15 and FSH. In both CC and CDO, there were no 226 
differences between treatments in regards to expression of glutathione synthesising (GSS, 227 
Figure 5A&B) and oxidising enzymes (GPX1 and GPX4, Figure 5G-N).  228 
 229 
There were similar patterns of mRNA expression of GSR and GSTA1, enzymes involved in the 230 
reduction of glutathione, within the oocyte (CDO). FSH supplementation, regardless of the 231 
presence or absence of BMP15, significantly reduced gene expression compared to the control 232 
group (main effect, Figure 5D&F, P < 0.05). Furthermore, GSTA1 was differentially expressed 233 
in cumulus cells, with significantly higher levels in +FSH alone compared to +BMP15; the 234 
opposite of what was seen in CDO (Figure 5E, P < 0.05). 235 
 236 
Therefore, while FSH and BMP15 did not affect the expression of genes involved in glutathione 237 
synthesis and oxidation, FSH treatment significantly influenced glutathione cycling by 238 
decreasing the gene expression of enzymes involved in the reduction of glutathione.  239 
 240 
Experiment 5: Amino acid turnover by intact cumulus oocyte complexes 241 
Amino acid turnover was measured in spent media from the final 4 h of IVM of individual COCs 242 
in the presence or absence of FSH and BMP15 as a marker of developmental competence. 243 
There were no significant differences in total, essential and non-essential amino acid turnover 244 
between treatments (Table 1). 245 
 246 
Isoleucine, serine and glutamine were the only amino acids that were consumed by COCs, with 247 
all other measured amino acid produced by COCs (Figure 6). Significant differences in 248 
glutamine turnover were observed (Figure 6), with the control group (-FSH –BMP15) producing 249 
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glutamine, compared to its consumption in the other treatment groups (-FSH -BMP15 = 16.4 ± 250 
23.4 vs. +FSH +BMP15 = -75.0 ± 16.5 pmol/COC/h; P < 0.05). Alanine turnover was also >2-251 
fold higher in the +FSH and +FSH +BMP15 groups compared to the control group (Figure 6; 252 
main effect of FSH, P < 0.05).  253 
 254 
DISCUSSION 255 
The addition of native OSF to oocyte maturation media through co-culture with denuded 256 
oocytes, or addition of recombinant OSFs improves oocyte developmental competence, on-257 
time embryo development rates and fetal survival post-embryo transfer (Hussein et al. 2006; 258 
Yeo et al. 2008; Hussein et al. 2011; Sudiman et al. 2014), possibly overcoming a deficiency in 259 
endogenous OSF production during IVM (Mester et al. 2014). We have previously 260 
demonstrated that the addition of recombinant, pro-mature BMP15 results in an altered 261 
metabolic profile to COCs exposed to FSH (the most widely used media additive during IVM 262 
which stimulates COC metabolism and oocyte developmental competence) or the combination 263 
of FSH and BMP15 (Sutton-McDowall et al. 2012). COCs cultured with BMP15 alone 264 
demonstrate a preference for oxidative metabolism, with less glucose metabolised via 265 
glycolysis and significant increases in intra-oocyte FAD (Figure 7).  Increased levels of 266 
NAD(P)H levels within the oocyte are also seen, without changing the REDOX ratio between 267 
treatment groups. Hence the aim of this study was to investigate the source of the increased 268 
NAD(P)H levels following culture in the presence of BMP15 and how this increase may be 269 
contributing to improved oocyte health, such as mitochondrial activity and the ability to deal 270 
with cellular stress.  271 
 272 
We hypothesised that the increase in oocyte NAD(P)H was attributed to increased NADPH 273 
production. Numerous studies have suggested that a major source of NADPH production within 274 
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the oocyte is via glucose metabolism by G6PDH, within the oxidative arm of the pentose 275 
phosphate pathway (Downs et al. 1998; Urner and Sakkas 2005). Brilliant cresyl blue (BCB) is 276 
metabolised by G6PDH (hence BCB negative oocytes indicate active G6PDH) and has been 277 
used to predict the developmental competence of immature oocytes prior to IVM (Roca et al. 278 
1998; Alm et al. 2005; Bhojwani et al. 2007). We exposed mature COCs to BCB following IVM 279 
with BMP15 and FSH to determined G6PDH activity. BMP15 supplementation resulted in lower 280 
proportions of BCB- oocytes, suggesting lower G6PDH and oxidative pentose phosphate 281 
pathway activity with BMP15 supplementation. In contrast, inhibiting IDH (TCA cycle) reduced 282 
the BMP15 stimulation of NAD(P)H auto-fluorescence, suggesting that a significant source of 283 
intra-oocyte NADPH is via the TCA-cycle, and BMP15 stimulation increases intra-oocyte TCA 284 
cycle activity. This is supported by Dumollard and colleagues (Dumollard et al. 2007b), who 285 
proposed that TCA cycle activity, especially IDH, contributes significantly to the intracellular 286 
REDOX potential in mouse oocytes. 287 
 288 
A major role of NADPH is the recycling of GSSG to GSH, allowing the cell to respond to 289 
oxidative stresses, such as H2O2 derived from oxidative phosphorylation within the 290 
mitochondria. FSH-stimulation (in the absence of BMP15) reduced the intensity of MCB 291 
staining within the oocyte, suggesting lower intra-oocyte levels of GSH, while BMP15 292 
supplementation (+FSH +BMP15) recovered MCB intensity. This concurs with the reduced 293 
gene expression of enzymes involved in the reduction of GSSG to GSH, namely GSR and 294 
GSTA1, within the oocyte following FSH stimulation. This suggests FSH stimulation reduces 295 
the ability for oocytes to regulate H2O2 levels through the reduction of GSSG to GSH. The 296 
increase in blastocyst development following IVM in the presence of both FSH and BMP15 297 
observed in previous studies (Sutton-McDowall et al. 2012) may be attributed to the BMP15-298 
induced increases in NADPH enabling a recovery of GSH levels.  299 
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 300 
The influence of BMP15 supplementation on oocyte and cumulus metabolism appears to vary 301 
with co-supplementation with different hormones and growth factors. The metabolism of 302 
oocytectomized complexes (intact COCs, in which the ooplasm has been surgically removed) 303 
did not differ from intact COCs or oocytectomized complexes co-cultured with denuded oocytes 304 
(Sutton et al. 2003), most likely due to FSH masking the stimulatory effects of BMP15 and 305 
other OSFs. More recently, EGF-like peptide amphiregulin supplementation with BMP15 further 306 
increases oocyte FAD and NAD(P)H (Sugimura et al. 2014), as opposed to the depression 307 
seen here with FSH-stimulation (Sutton-McDowall et al. 2012). 308 
 309 
FSH was used in the current study as it is a widely used addition to cattle IVM systems to 310 
stimulate maturation and other cellular activities such as glucose metabolism (Sutton-McDowall 311 
et al. 2010). However, it is becoming increasingly evident that alternative hormones and growth 312 
factors should be explored for use in IVM systems, given the potential for increased cellular 313 
stress induced by FSH in the current study. As mentioned above, EGF-like peptides are ideal 314 
candidates given their addition improves development competence by prolonging gap junction 315 
communication between the oocyte and cumulus cells (Sugimura et al. 2014) and stimulation of 316 
glucose metabolism and cumulus expansion in mouse COCs (Richani et al. 2014). 317 
 318 
In addition to measuring mean fluorescence intensity of MCB, Mitotracker Red and PF1, the 319 
texture of staining (grey-level co-occurrence matrices) were assessed as an indicator of the 320 
localisation and uniformity of positive fluorescence staining. Mitochondria synthesis occurs 321 
during oocyte development and remains static until implantation. In addition to copy number, 322 
mitochondrial distribution within the oocyte is constantly changing in response to energy 323 
expensive events such as meiotic progression (Van Blerkom 2009) and activity is largely 324 
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influenced by location (Diaz et al. 1999). Immature oocytes (germinal vesicle stage) 325 
demonstrate a cortical pattern of mitochondrial localisation, verses a more disperse, even 326 
distribution in mature (metaphase II, MII) oocytes (Dumollard et al. 2007a). However, clustering 327 
or uneven distribution within MII oocytes is associated with compromised developmental 328 
competence (Van Blerkom 2009). In the current study, BMP15 supplementation resulted in 329 
“smoother” and more homogenous localisation of both Mitotracker Red and PF1 staining within 330 
mature oocytes, regardless of FSH-stimulation. Furthermore, there was less variation in texture 331 
within the +BMP15 and +BMP15 +FSH treatment groups, in particular compared to the –332 
BMP15 –FSH group. This suggests BMP15 supplementation during IVM is promoting an even 333 
distribution of active mitochondria, contributing to improved function and developmental 334 
competence.  335 
 336 
A unique aspect of this study was the use of fluorescence probes in single, live oocytes to 337 
investigate cellular metabolism. Where traditional enzymatic assays require pooling large 338 
numbers of COCs/oocytes for the assessment of single enzymes, in the current study 339 
fluorescence probes were used determine the level and localisation of reactive oxygen species, 340 
anti-oxidants (specifically H2O2 and GSH) and active mitochondria within the oocyte following 341 
the culture of intact COCs in the presence of BMP15 and FSH. This technique allowed the 342 
creation of a profile of three metabolic outcomes; with positive staining indicating levels of 343 
enzymatic activity, localisation and textural patterning, within single live oocytes, vs. large 344 
numbers of pooled oocytes for traditional enzymatic assays. The use of quantitative texture 345 
analyses further enhanced the interpretation of imaging data. Grey-level co-occurrence 346 
matrices (GLCM) have been extensively utilised in diagnostic imaging (Castellano et al. 2004) 347 
and applied in dermatology (Mittra and Parekh 2011), liver (Losa and Castelli 2005) and cancer 348 
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imaging (Alvarenga et al. 2007).  To our knowledge, this is the first study to present the results 349 
of such image analyses to investigate patterns of metabolism within oocytes. 350 
 351 
Differences in amino acid profiles of oocytes denuded of their cumulus vestment compared to 352 
intact COCs are highlighted by a recent study of oocyte metabolism during the final 6 h of IVM 353 
(Hemmings et al. 2012). Cattle oocytes that underwent successful fertilisation, cleavage and 354 
developed to the blastocyst stage (on-time embryo development) had lower glutamine uptake 355 
and alanine appearance in media compared to incompetent oocytes (uncleaved following 356 
fertilisation) (Hemmings et al. 2012). Likewise, in the current study, glutamine and alanine were 357 
influenced by treatments. Glutamine consumption and alanine production was significantly 358 
higher in COCs that were incubated with treatments that resulted in improved oocyte 359 
developmental competence. Both glutamine and alanine are involved in carbohydrate 360 
metabolism, with high levels of glutamine consumption seen in pre-cancerous and cancerous 361 
cells (Varone et al. 2014) and alanine is involved in ammonium detoxification (Schliess et al. 362 
2014). Alanine production was highest in the FSH treatment groups (regardless of BMP15), 363 
both of which had the highest levels of glycolytic activity (Sutton-McDowall et al. 2012). Indeed, 364 
a recent study demonstrated a link between alanine and glutamine levels in follicular fluid and 365 
developmental competence of oocytes (Matoba et al. 2014). 366 
 367 
Both glutamine metabolism and pyruvate oxidation within cattle oocyte significantly increased 368 
towards the end of maturation as measured in denuded oocytes following COC maturation 369 
using radiolabelled substrates (Rieger and Loskutoff 1994; Steeves and Gardner 1999).  370 
Therefore, it seems reasonable to suggest that within treatments impacting oxidative 371 
phosphorylation, such as the addition of BMP15, greater levels of glutamine are also 372 
metabolised within the oocyte.  However, we did not assess this directly in the current study. 373 
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 374 
In conclusion, we found that BMP15 supplementation during bovine oocyte IVM stimulates 375 
NADPH production via IDH and the TCA cycle within the oocyte, rather than G6PDH (pentose 376 
phosphate pathway), further supporting the role of BMP15 in inducing oxidative metabolism 377 
within the oocyte. Furthermore, BMP15 supplementation (regardless of FSH) promoted a more 378 
homogenous and consistent localisation of active mitochondria, indicative of improved 379 
developmental competence. FSH reduces GSH levels within the oocyte, corresponding with 380 
reduced gene expression of glutathione reducing enzymes. The combination of both FSH and 381 
BMP15 significantly increased glutamine consumption, consistent with increased oxidative 382 
metabolism. Hence, significant increases in oocyte developmental competence previously 383 
reported is likely to due the combination of FSH and BMP15 resulting in equilibration of 384 
metabolism within the oocyte, rather than a preference for oxidative or reductive metabolism; 385 
for example, FSH stimulated glucose metabolism within the cumulus vestment, while BMP15 386 
promoted oxidative phosphorylation through improved mitochondrial function and protection 387 
against cellular stress, through increased NADPH production promoting improved glutathione 388 
recycling.  389 
 390 
MATERIALS AND METHODS 391 
Unless stated, all chemicals were obtained from Sigma Aldrich (St Louis, MO).  392 
 393 
Oocyte collection and in vitro maturation (IVM)  394 
Cattle ovaries were collected from a local abattoir (T&R, Murray Bridge, South Australia) and 395 
transported to the laboratory in warm saline (30-35°C). Immature COCs were aspirated from 396 
ovarian follicles using an 18-gauge needle and a 10 ml syringe, in undiluted follicular fluid. 397 
Compact COCs with intact cumulus vestments, with at least three cell layers and un-granulated 398 
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ooplasms were selected in undiluted follicular fluid, washed once in IVM medium and then 399 
transferred into the corresponding IVM treatments. The IVM media was bicarbonate buffered 400 
TCM199 (ICN Biochemicals; Irvine, CA USA) + 0.5 mM pyruvate + 4 mg/ml fatty acid free 401 
(FAF) BSA (ICPBio Ltd; Auckland, New Zealand) + 100 mIU/ml FSH (Puregon; Organon, Oss, 402 
Netherlands) + 100 ng/ml BMP15, a concentrated preparation of recombinant human BMP15 403 
pro/mature complex produced in our laboratory using 293T cells, as previously described 404 
(Pulkki et al. 2011; Mottershead et al. 2012). Groups of 10 COCs were cultured in 100 μl of pre-405 
equilibrated IVM media, overlaid with paraffin oil (Merck; Darmstadt, Germany) at 38.5°C in 6% 406 
CO2 in humidified air. Unless otherwise stated, COCs were cultured for 23 h.  407 
 408 
Experiment 1: Intra-oocyte glucose 6-phosphate dehydrogenase (G6PDH) activity  409 
After 21.5 h of culture + FSH + BMP15, COCs were transferred into fresh IVM media + 23 μM 410 
brilliant cresyl blue (BCB) and cultured for 90 mins at 38.5°C. At the completion of culture, 411 
COCs were washed once in wash medium (VitroWash; IVF Vet Solutions, Adelaide, Australia + 412 
4 mg/ml FAF BSA) and staining of the oocyte was assessed using a dissecting microscope. 413 
BCB is readily metabolised by G6PDH, hence blue oocytes (BCB+) arise from COCs with low 414 
G6PDH activity and BCB- oocytes from COCs with high G6PDH activity. Data are presented as 415 
the proportion of BCB negative (-) oocytes from the total oocyte pool for each treatment and 416 
replicate. Four replicate experiments were performed with 20-30 COCs used within each 417 
treatment group and replicate.  418 
 419 
Experiment 2: Intra-oocyte isocitrate dehydrogenase (IDH) activity and NAD(P)H levels  420 
Following 23 h of culture in IVM media without FSH + 100 ng/ml BMP15, COCs were 421 
transferred into VitroWash + 4 mg/ml FAF BSA and 0 or 1 mM oxalomalate (an inhibitor of 422 
IDH). A dose response of oxalomalate revealed that media containing 2 mM oxalomalate or 423 
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higher had high levels of background fluorescence; hence 1 mM oxalomalate was used in 424 
subsequent experiments (Supplementary Figure S1). COCs were transferred in 5 μl of 425 
corresponding wash medium (± oxalomalate), overlaid with oil in glass bottom confocal dishes 426 
(Cell E&G; Houston, TX, USA). Auto-fluorescence images were captured for live oocytes, using 427 
the FluoView FV10i confocal microscope and accompanying software (Olympus; Tokyo, 428 
Japan), measuring green (FAD; excitation = 473 nm and emission = 490-590 nm) and blue 429 
(NADH/NADPH = NAD(P)H; excitation = 405 nm and emission = 420-520 nm) emissions using 430 
inbuilt filters. Microscope settings such as laser intensity and image size were kept constant. 431 
Quantification of the fluorescence intensity was determined using Image J imaging software 432 
(NIH; Bethesda, MD, USA), with the raw data normalised to fluorescence beads (InSpeck, 433 
Molecular Probes; Eugene, OR, USA). Three replicate experiments were performed with 10 434 
COCs measured per treatment group, per replicate.  435 
 436 
Experiment 3: Intra-oocyte reduced glutathione (GSH), mitochondrial activity and 437 
reactive oxygen species (ROS) levels 438 
After 23 h of culture, COCs were denuded by repeat pipetting and transferred into VitroWash + 439 
4 mg/ml FAF BSA + 20 μM peroxyfluor-1 (PF1) for 1 h; 12.5 μM monochlorobimane (MCB) for 440 
30 mins and 200 nM Mitotracker Red CMXROS (Molecular Probes) for 15 mins at 38.5°C, in 441 
darkness. Oocytes were washed once in VitroWash + 4 mg/ml FAF BSA and transferred into 2 442 
μl smears of wash medium in glass bottom confocal dishes.  443 
 444 
PF1 is an aryl boronate probe that fluoresces on reaction with H2O2 (Chang et al. 2004). It has 445 
higher specificity for H2O2 and peroxynitrite over other ROS, unlike commonly used non-446 
specific ROS probes such as 2’,7’-dichlorohydrofluorescein diacetate (H2DCFDA). H2DCFDA 447 
also autoxidizes and catalyzes superoxide production, leading to false positive fluorescence 448 
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(Murphy et al. 2011). PF1 was prepared using microwave irradiation in place of conventional 449 
heating: 3’,6’-diiodofluoran (Chang et al. 2004) (89 mg, 0.16 mmol), bis(pinacolato)diboron (160 450 
mg, 0.63 mmol), potassium acetate (141 mg, 0.63 mmol) and Pd(dppf)Cl2 (14 mg, 0.02 mmol) 451 
were pre- dried in vacuo, dissolved in DMF (4 ml) under N2 atmosphere in a sealed microwave 452 
vial fitted with a teflon cap. The light brown mixture was reacted in a CEM Discover microwave 453 
synthesiser (Matthews, NC) at 80 °C for 2 h. The solvent was removed under reduced 454 
pressure to give a dark brown powder which was purified by column chromatography eluting 455 
with 4:1 hexane:ethyl acetate to give PF1 as a white solid. (40 mg, 45%); 1HNMR (CDCl3, 456 
300MHz): δ(ppm) 8.03 (1H, m), 7.74 (2H, s), 7.60 (2H, m), 7.43 (2H, dd, J1=7.8Hz, J2=1.1Hz), 457 
7.06 (1H, m), 6.86 (2H, d, J=7.8Hz), 1.35 (24H, s). 458 
 459 
Both MCB and Mitotracker Red CMXROS are commercially available fluorescent probes. MCB 460 
fluoresces when bound to low weight thiol compounds, with the highest affinity for reduced 461 
glutathione (GSH), representing 99% of the intracellular fluorescence intensity (Keelan et al. 462 
2001). Mitotracker Red CMXROS accumulates within mitochondria, depending on membrane 463 
potential.  464 
 465 
Intra-oocyte fluorescence was captured using the Fluoview FV10i confocal microscopy (MCB: 466 
excitation = 358 nm and emission = 461 nm; PF1: excitation = 496 nm and emission = 519; 467 
Mitotracker Red: excitation = 578 nm and emission = 598) with laser, magnification and image 468 
settings remaining constant across replicates.  469 
 470 
Image processing and analyses were performed using Image J software and the plugin/macro 471 
option, hence allowing for semi-automated analyses. Macros for image file processing and 472 
measurements are included as supplementary data. Briefly, using Macro 1 (supplementary 473 
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data), individual images were captured, representing each fluorescent channel, and then 474 
converted from Olympus confocal image files (Olympus image format, oif) into 8-bit grey scale 475 
tiff files. The oocyte was selected as a region of interest (ROI) and the background of the image 476 
was excluded. Mean intensity (Macro 2, supplementary data) and selected texture features 477 
analyses (grey-level co-occurrence matrices, GLCM, Macro 3) of the ROI were performed. 478 
Macros 2 and 3 are available from the NIH Image J website (http://rsb.info.nih.gov/ij/plugins). 479 
GLCM analysis was applied to determine differences in the localisation of fluorescence 480 
intensity, hence the texture (uniformity/smoothness/roughness) of staining patterns (Haralick et 481 
al. 1973; Murata et al. 2001; Cabrera 2006). Angular secondary moment (ASM) represents the 482 
texture of the whole oocyte, contrast represents the texture of sub-cellular organelles and 483 
correlation represents intensity differences between pixels. A total of 10 COCs used per 484 
treatment. 485 
 486 
The relationship between MCB fluorescence and intra-oocyte GSH levels was validated by 487 
incubating COCs in buthionine sulphoximine (BSO), an inhibitor of the first stage of glutathione 488 
synthesis (gamma-glutamylcysteinesynthetase). Groups of 10 COCs were cultured in VitroMat 489 
+ 4 mg/ml FAF BSA + 0.1 IU/ml FSH and 0, 1, 2, 5 and 10 mM BSO. After 23 h of culture, 490 
COCs were incubated with 12.5 μM MCB (as above) and fluorescence intensity was 491 
determined within denuded oocytes. Results of the dose response are present in 492 
Supplementary Figure S3. Two replicate experiments were performed, with 10 COCs per 493 
replicate.  494 
 495 
Experiment 4: Gene expression within the oocyte and cumulus vestment 496 
Total RNA from 50 COC-derived oocytes (CDO) or the cumulus cells (CC) from 50 COCs was 497 
isolated using Trizol according to manufacturer’s instructions (Life Technologies; Mulgrave, 498 
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VIC, Australia).  Total RNA was treated with 1 IU DNAse (Life Technologies) at 37°C for 1 h as 499 
per manufacturer’s instructions.  First strand complementary DNA (cDNA) was synthesised 500 
using random hexamer primers and Superscript III reverse transcriptase (Life Technologies).  501 
Gene primers for Real Time RT-PCR were designed against published mRNA sequences from 502 
the NCBI Pubmed Database using Primer 3 software (Table 2) and synthesised by Geneworks 503 
(Geneworks, Adelaide, SA, Australia).  Real time RT-PCR was performed in triplicate for each 504 
sample on a Rotor-Gene™ 6000 (Corbett Life Science; Sydney, NSW, Australia).  In each 505 
reaction, 506 
Master Mix (Applied Biosystems; CA, USA), and water was added to a final volume of 10 507 
primers were used at an optimised concentration of 25 as follows: 508 
50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 60 sec.  509 
Single product amplification was confirmed by analysis of disassociation curves and ethidium 510 
bromide stained agarose gel electrophoresis.  Controls included the absence of cDNA template 511 
or the reverse transcriptase enzyme and each showed no evidence of product amplification or 512 
genomic DNA contamination.  All gene expression was normalised to an RPL19 (L19) internal 513 
loading control that was amplified in parallel for each sample.  Results were then expressed as 514 
a raw expression value using the 2-(ΔΔCT) method. 515 
 516 
Experiment 5: Amino acid turnover by intact cumulus oocyte complexes 517 
Groups of 10 COCs were cultured + FSH + BMP15. After 19 h of culture, individual COCs were 518 
transferred into 2 μl drops of fresh culture medium and cultured for 4 h. At the completion of the 519 
culture period, the COC was removed, 1 μl of the spent medium was transferred into a 1.7 ml 520 
eppendorf tube, snap frozen, freeze dried and stored at -80°C. In addition, for each treatment 521 
and replicate a drop of media without a COC was cultured simultaneously to account for amino 522 
acid concentrations within the media.  523 
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 524 
Freeze dried samples were analysed for amino acid composition using a protocol similar to 525 
(Wale and Gardner 2012). Amino acid analysis was undertaken using the derivatization-526 
labeling reagent 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (Aqc) and a triple-527 
quadrupole mass spectrometer (LC-QqQ-MS), to facilitate the concentrations of co-eluted 528 
fractions of a variety of amines to be resolved and quantitated by comparison against a 529 
standard calibration curve. A 2.5_mM stock solution of amino acids was prepared containing 530 
the following; lysine, histidine, asparagine, arginine, taurine, serine, glutamine, glycine, 531 
aspartate, glutamate, threonine, alanine, proline, cysteine, tyrosine, methionine, valine, 532 
isoleucine, leucine, phenylalanine and tryptophan. Calibration standards for these amino acids 533 
were then prepared by diluting the stock solution to 150, 100, 50, 25, 10, 5, 1, 0.5, 0.1, 0.05, 534 
and 0.01 μM in water using volumetric glassware.  Norleucine was used as an internal standard 535 
in borate buffer containing the antioxidant ascorbic acid and the reducing agent tris(2-536 
carboxyethyl)phosphine.  Each dried media sample, including a control media sample not used 537 
for COC incubation, was resuspended in 10 μL of MilliQ water and 10 μl aliquots of each amino 538 
acid standard prepared.  To all standards and samples, 70 μl of borate buffer was then added 539 
and mixed by vortex for 20 sec followed by centrifugation (1 min). To each 80 μl volume, 20 μl 540 
of Aqc was added and the solution, vortexed immediately for 20 sec, and warmed on a heating 541 
block (Thermomixer, Eppendorf) with shaking (1000 rpm) for 10 min at 55°C. The final solution 542 
was then allowed to cool to ambient temperature before centrifugation (1 min), followed by 543 
analysis using an Agilent 1200 LC-system coupled to an Agilent 6420 ESI-QqQ-MS (Santa 544 
Clara, CA). 545 
 546 
The amino acid concentrations in spent media were normalised against a drop of media that 547 
had been cultured without a COC and consumption/production were calculated as pmol per 548 
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COC per hour of culture (4 h). A negative value indicates net depletion/consumption, with 549 
positive values representing production/appearance in the COC media samples. Four 550 
experimental replicates were performed, with the spent media from two individual COC cultures 551 
collected per treatment group, within replicates.  552 
 553 
Statistical analyses 554 
Differences between treatments were determined using a general linear model, with BMP15 555 
and FSH as main effects with the exception of experiment 2, in which the main effects were 556 
BMP15 and oxalomalate. Differences between individual treatment groups were determined 557 
using the Bonferroni post-hoc test. Proportional data was arcsine transformed prior to analysis. 558 
All statistical tests were performed using SPSS version 22 statistical software and P-values 559 
less than 0.05 were considered statistically significant. 560 
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FIGURE AND TABLE LEGENDS 748 
Figure 1. The influence of FSH and BMP15 supplementation during oocyte maturation on 749 
glucose 6-phosphate dehydrogenase activity, as determined by brilliant cresyl blue (BCB) 750 
staining within the oocyte. Bars represent means + SEM and different superscripts indicate 751 
significant differences (ab P < 0.05).  752 
 753 
Figure 2. Following 23 h of culture in the presence or absence of BMP15 (no FSH), COCs 754 
were treated with oxalomalate (ox; an inhibitor of isocitrate dehydrogenase) and A) NAD(P)H 755 
and B) FAD autofluorescence within the oocyte was measured. Bars represent means + SEM 756 
and different superscripts indicate significant differences (ab P < 0.05). 757 
 758 
Figure 3. Anti-oxidants, mitochondrial activity and reactive oxygen species (ROS) levels within 759 
oocytes following IVM in the presence of FSH and BMP, as indicated by the mean intensities of 760 
A) monochloridebimane (MCB, reduced glutathione, GSH); B) mitotracker red (active 761 
mitochondria) and C) peroxyfluor 1 (PF1, H2O2). Bars represent means + SEM and different 762 
superscripts indicate significant differences (abc P < 0.05). D) Representative images of the 763 
positive staining. The scale bar = 50 μM. 764 
 765 
Figure 4. Textural analyses, indicated by angular secondary moment, of anti-oxidants, 766 
mitochondrial activity and reactive oxygen species (ROS) levels within oocytes following IVM in 767 
the presence of FSH and BMP, as indicated by the textural values of A) monochloridebimane 768 
(MCB, reduced glutathione, GSH); B) mitotracker red (active mitochondria) and C) peroxyfluor 769 
1 (PF1, H2O2). Data points indicate individual oocytes, bars represent means + SEM and 770 
different superscripts indicate significant differences (ab P < 0.05). 771 
 772 
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Figure 5. mRNA expression of enzymes involved in NADPH metabolism and glutathione. Intact 773 
COCs were cultured in the presence or absence of BMP15 and FSH and separated into COC-774 
derived oocyte (CDO) and cumulus cells (CC). Bars represent means + SEM and different 775 
superscripts indicate significant differences (ab P < 0.05). 776 
 777 
Figure 6. Amino acid turnover by intact COCs cultured in the presence and absence of FSH 778 
and BMP15. Bars represent means + SEM and different superscripts indicate significant 779 
differences (abxy P < 0.05). 780 
 781 
Figure 7. A summary of the changes in metabolism within the cumulus cells and oocytes 782 
treated with FSH and BMP15. Previous studies have demonstrated that the presence of both 783 
FSH and BMP15 during IVM significantly increased blastocyst development rates (total 784 
blastocysts from cleaved) to 52% compared to 28% -FSH –BMP15, (Sutton-McDowall et al. 785 
2012). Despite similar blastocyst development rates, when FSH and BMP15 were added 786 
separately during IVM (+FSH = 44% and +BMP15 = 41%), different metabolic profiles were 787 
observed in the COCs. The presence of FSH alone induces higher levels of glucose 788 
metabolism within the cumulus cells via glycolysis and hexosamine biosynthetic pathway 789 
(HBP), hence extra cellular matrix formation. Conversely, the presence of BMP15 alone 790 
promotes higher levels of FAD and NADPH/NADH levels within the oocyte. In the current 791 
study, BMP15 induced NADPH production via the TCA cycle. Furthermore, mitochondrial 792 
localisation is more uniform in oocytes treated with BMP15. FSH-stimulated reduces GSH 793 
levels and the gene expression of enzymes involved in glutathione reduction, compromising the 794 
ability for oocytes to recycle glutathione in response to increased H2O2 production from 795 
increased mitochondrial activity. BMP15 treatment also resulted in increased H2O2 production, 796 
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however, higher levels of GSH, NADPH and improved mitochondrial localisation could 797 
counteract this.  798 
 799 
 800 
Supplementary Figure S1: Background fluorescence of oxalomalate using blue (ex = 405, em 801 
= 420/520) and green (ex = 473, em = 490-540) filters. Bars represent means + SEM and 802 
different letters within outputs are significantly different (ab P < 0.05).  803 
 804 
Supplementary Figure S2: Grey-level co-occurrence matrices (GLCM) as a measure of 805 
texture of positive staining. A-C) monochlorobimane (MCB, reduced glutathione, GSH); D-F) 806 
mitotracker red (active mitochondria) and G-I) peroxyfluor 1 (PF1, H2O2). GLCM outputs 807 
include angular secondary moment (ASN), contrast and correlation. Data points represent 808 
individual oocytes and bars represent mean + SEM. Different superscripts indicate significant 809 
differences (ab P < 0.05).  810 
 811 
Supplementary Figure S3: Validation of monochlorobimane (MCB) detection of reduced  812 
glutathione (GSH) within oocytes by culturing COCs in increasing doses of 813 
buthioninesulphoximine (BSO), an inhibitor of glutathione synthesis. Bars represent means + 814 
SEM and different letters within outputs are significantly different (ab, x P < 0.001). 815 
 816 
Table 1. Total amino acid, essential (EA) and non-essential (NEA) amino acid turn over by 817 
COCs following cultured in the presence or absence of FSH and BMP15. 818 
 819 
Values represent means ± SEM. Negative values represent consumption and positive values 820 
represent production.  821 
Manuscript 36 
 822 
Table 2. Gene and primer data. 823 
 824 
SUPPLEMENTARY DATA 825 
Macro 1 (Image processing) 826 
open(); 827 
run("8-bit"); 828 
run("Fit Circle"); 829 
// draw circle around embryo and need to insert a command window 830 
makeOval; 831 
setBackgroundColor(255, 255, 255); 832 
run("Clear Outside"); 833 
saveAs("Tiff"); 834 
 835 
Macro 2 (Batch Intensity Measure) 836 
macro "Batch Measure" { 837 
    dir = getDirectory("Choose a Directory "); 838 
    list = getFileList(dir); 839 
    if (getVersion>="1.40e") 840 
        setOption("display labels", true); 841 
    setBatchMode(true); 842 
    for (i=0; i<list.length; i++) { 843 
        path = dir+list[i]; 844 
        showProgress(i, list.length); 845 
        if (!endsWith(path,"/")) open(path); 846 
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        if (nImages>=1) { 847 
            run("Measure"); 848 
            close(); 849 
        } 850 
    } 851 
} 852 
 853 
Macro 3 (Batch GLCM Measurements) 854 
macro "Batch GLCM Measure" { 855 
    dir = getDirectory("Choose a Directory "); 856 
    list = getFileList(dir); 857 
    step = getNumber("Enter the size of the step in pixels: ", 1); 858 
    setBatchMode(true); 859 
    print("#,","Angular Second Moment,","Contrast,","Correlation,","Inverse Difference 860 
Moment,","Entropy,"); 861 
    for (i=0; i<list.length; i++) { 862 
        path = dir+list[i]; 863 
        showProgress(i, list.length); 864 
        if (!endsWith(path,"/")) open(path); 865 
        if (nImages>=1) { 866 
            run("GLCM Texture", "enter="+step+ " select=[0 degrees] angular contrast correlation 867 
inverse entropy"); 868 
            close(); 869 
            asm = getResult("Angular Second Moment",0);  870 
            contrast = getResult("Contrast",0); 871 
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            correlation = getResult("Correlation",0); 872 
            idm = getResult("Inverse Difference Moment   ",0); //Extra spaces needed due to 873 
source code error 874 
            entropy = getResult("Entropy",0); 875 
            print(list[i],",",asm,",",contrast,",",correlation,",",idm,",",entropy); 876 
        } 877 
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